Unlocking the Power of the Genome
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Illumina | Sequencing and array solutions to fuel genomic discoveries
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
Bio-Rad Laboratories Biotechnology Research | Not capitalistic Partnership Not event 28 May 2017 | | ||
QB3 Biotechnology Research | Other 23 Sep 2015 | | ||
NanoString Technologies, Inc. biotech, deeptech, Biotechnology Research | Not capitalistic Not partnership Event 18 Oct 2021 | | ||
Juno Bio healthtech, Biotechnology Research | Not capitalistic Not partnership Event 30 Nov 2021 | | ||
Alzheimer's Research UK Non-profit Organizations | Other 23 Feb 2022 | |